Value Adjusted for Debt and Cash: artivion.com (AORT)

Graphic logo of Artivion Corp (AORT)

This daily price chart for Artivion, Inc. (AORT) reflects an enterprise value of 1431.57. Artivion, Inc. (AORT) develops cardiac implants, where R&D costs are recouped through the low-cost scaling of FDA-certified products. High margins are sustained by exclusive patents and surgeon confidence in clinical data, which creates significant barriers to entry for new players.

Artivion Inc - AORT Total Company Value (period 11/23/2025 - 11/01/2026)

Artivion, Inc. (AORT) - metric breakdowns and financial figures

- market value and analyst target forecast:
Market Price CryoLife|AORT - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Artivion|AORT - Real Price to Acquire Entire Company
- book capitalization information:
Book Price of a Share Artivion|AORT - Company Book Value|Market Capitalization to Book Value artivion.com|AORT - Aggregate Company Assets
- company total debt and liquidity indicators:
Aggregate Debt to Equity Artivion, Inc.|AORT - Long-Term Debt to Capital|Current Liabilities to Capital artivion.com|AORT - Company Aggregate Debts|Debt to Book Value Artivion|AORT - Company Long-Term Debts|Short-Term Debt Volume Artivion|Quick Ratio artivion.com
- financial results and valuation multiples details:
AORT - Company Net Income
Summary company analytics:AORT - CryoLife
Finished products of Artivion Inc

Steady demand for Artivion, Inc. (AORT) cardiovascular grafts and bioadhesives forms the foundation of its market value. By analyzing the EV trend, an investor assesses the total cost of acquiring the business—combining market capitalization with net debt minus liquid assets—which allows for the determination of the enterprise's real value and the identification of hidden capital overvaluation risks.

Who Artivion, Inc. competes with

Boston Scientific Corp (BSX) - Total Enterprise Value|EW - Total Company Value|Value Adjusted for Debt and Cash RMD (ResMed Corporation)|PODD (Insulet Corporation) - Real Price to Acquire Entire Company|ZBH: Aggregate Business Value|Total Company Value CooperCompanies|Invisalign (ALGN) - Company Buyout Price|Total Company Value Globus Medical Corp (GMED)|TMDX: Full Business Value|Enterprise Value ATEC (Alphatec Holdings, Inc.)|enovis.com (ENOV) - Total Enterprise Value|Integra LifeSciences Holdings Corporation - Enterprise Value|Establishment Labs Corp (ESTA) - Real Price to Acquire Entire Company|BBNX: Enterprise Value|IRMD - Company Buyout Price|EMBC (Embecta Corp.) - Enterprise Value|Enterprise Value tandemdiabetes.com|Total Company Value Axogen (AXGN)|Total Company Value SIBN (SI-BONE Inc)|Enterprise Value OFIX (Orthofix International)|Company Buyout Price Bioventus Global (BVS)|KIDS: Real Price to Acquire Entire Company|Full Business Value TMCI|SRTA: Enterprise Value|Total Enterprise Value Carlsmed, Inc. (CARL)|RXST (RxSight Corp) - Enterprise Value|Business Value CLPT (ClearPoint)|Real Price to Acquire Entire Company STXS (Stereotaxis, Inc.)|STIM (neurostar.com) - Value Adjusted for Debt and Cash|Total Company Value Sight Sciences SGHT|OBIO - Real Price to Acquire Entire Company|Anika - Enterprise Value|Total Enterprise Value InspireMD Inc.|ZJYL: Enterprise Value|Business Value VANI|XTNT (Xtant Medical Holdings, Inc.) - Enterprise Value|NeuroOne (NMTC) - Company Buyout Price|Enterprise Value MODD|Real Price to Acquire Entire Company Myomo Inc MYO|Enterprise Value COCH (Envoy Medical, Inc.)|Enterprise Value vivoslife.com VVOS|NVNO - Total Company Value|SINT: Total Company Value|TNON (Tenon Medical, Inc) - Real Price to Acquire Entire Company|Lifeward Ltd. - Value Adjusted for Debt and Cash|AMIX (Autonomix Medical Inc.) - Enterprise Value|Total Enterprise Value invobioscience.com IVF|Total Company Value Bone Biologics Corp (BBLG)|Axonics Inc. (AXNX) - Full Takeover Company Value|Biolase, Inc. - Real Price to Acquire Entire Company|Enterprise Value Dynatronics Corp DYNT|Paragon 28 Corp - Enterprise Value|Company Buyout Price INVO Bioscience, Inc. INVO